Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6300153 | 0.77 | CYP3A4 (0.38) | PTGS2ALDH1A1LMNAHPGDTDP1 | |
| SCHEMBL6300151 | 0.77 | CYP3A4 (0.38) | PTGS2ALDH1A1LMNAHPGDTDP1 | |
| SCHEMBL28745239 | 0.76 | PTGS2 (0.40) | PTGS2ALDH1A1HTTNPSR1LMNA | |
| SCHEMBL879008 | 0.75 | PTGS2 (0.49) | PTGS2ALDH1A1LMNAHPGDTDP1 | |
| SCHEMBL10434287 | 0.75 | PTGS2 (0.42) | PTGS2ALDH1A1HTTNPSR1LMNA | |
| SCHEMBL8053369 | 0.75 | PTGS2 (0.69) | PTGS2ALDH1A1HTTNPSR1LMNA | |
| SCHEMBL2925327 | 0.75 | PTGS2 (0.69) | PTGS2ALDH1A1HTTNPSR1LMNA | |
| SCHEMBL9617925 | 0.74 | ALDH1A1 (0.42) | PTGS2ALDH1A1LMNATDP1PKM | |
| SCHEMBL2509405 | 0.71 | PTGS2 (0.42) | PTGS2ALDH1A1HTTNPSR1LMNA | |
| SCHEMBL8056495 | 0.71 | PTGS2 (0.54) | PTGS2ALDH1A1HTTNPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7029764-B2 | Organic electroluminescent material and electroluminescent device by using the same | RITDISPLAY CORPORATION (TW) | 2006-04-18 | — | — | US | disclosed |
| US-7026061-B2 | Organic electroluminescent material and organic electroluminescent element by using the same | RITDISPLAY CORPORATION (TW) | 2006-04-11 | — | — | US | disclosed |
| US-20060063034-A1 | Organic electroluminescent material and organic electroluminescent device by using the same | RITDISPLAY CORPORATION | 2006-03-23 | — | — | US | disclosed |
| US-20040183432-A1 | Organic electroluminescent material and organic electroluminescent element by using the same | RIT DISPLAY CORPORATION (TW) | 2004-09-23 | — | — | US | disclosed |
| US-20040146742-A1 | Organic electroluminescent material and electroluminescent device by using the same | RITDISPLAY CORPORATION (TW) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063034-A1 | Organic electroluminescent material and organic electroluminescent device by using the same | PIEZO1, L1CAM, OR10J3 | PTGS2 2945/4885ALDH1A1 135/4885HTT 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.